Nazione: Irlanda
Lingua: inglese
Fonte: HPRA (Health Products Regulatory Authority)
GLIBENCLAMIDE
Chanelle Healthcare Limited
GLIBENCLAMIDE
5 Milligram
Tablets
Product subject to prescription which may be renewed (B)
Authorised
0000-00-00
ID: PL 43 IE VERSION: 04 EFFECTIVE DATE: 20/01/14 PACKAGE LEAFLET: INFORMATION FOR THE USER GLIBENCLAMIDE 5 MG TABLETS Glibenclamide IN THIS LEAFLET: 1. What Glibenclamide is and what it is used for. 2. Before you take Glibenclamide. 3. How to take Glibenclamide. 4. Possible side effects. 5. How to store Glibenclamide. 6. Further Information. Glibenclamide is a medicine taken by mouth to help lower blood sugar. It belongs to a group of medicines called sulfonylureas. Glibenclamide works by increasing the amount of insulin released from your pancreas. The insulin then lowers your blood sugar levels. Glibenclamide is used to treat a certain form of diabetes (type 2 diabetes mellitus), when diet, physical exercise and weight reduction alone have not been able to control your blood sugar levels. DO NOT TAKE GLIBENCLAMIDE TABLETS IF • you are allergic (hypersensitive) to glibenclamide, sulphonamides (medicines for bacterial infection) or any of the other ingredients of Glibenclamide. • you have diabetic ketoacidosis (a complication of diabetes with some of the following signs: fatigue, nausea (feeling sick), frequent urination and muscular stiffness) • you have experienced unusual breathing, strong smelling breath, or suffered from confusion, fainting or even coma as a result of your illness. • you have insulin dependent mellitus diabetes which does not respond to dietary measures alone. • you have juvenile or “brittle” diabetes. • you have sulphonylurea or sulphonamide intolerance. • you are pregnant or breast-feeding a baby. • you have kidney or liver problems, or specific hormone requirements. • you are taking medicines for the heart (e.g. bosentan used to treat high blood pressure) Do not take this Leggi il documento completo
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Glibenclamide 5 mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 5mg glibenclamide. This product also contains 103mg lactose monohydrate per tablet. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet. A plain, round, flat bevelled edge, 8.5mm white tablet, with a breakline on one side. The tablet can be divided into equal halves. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Glibenclamide is a sulphonylurea hypoglycaemic agent indicated for the oral treatment of patients with non-insulin dependent diabetes who respond inadequately to dietary measures alone_._ 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Oral Use GENERAL INSTRUCTIONS The dosage of glibenclamide must be the lowest possible dose which is effective. The usual total daily dosage is 2.5 to 15 mg daily with a usual initial dose of 5 mg daily. Weekly adjustments can be made to increase the dosage to the optimal level. Doses of 10 mg or less may be taken as a single dose immediately before/after breakfast, but should the daily dose exceed 10 mg, the remainder should be taken immediately before/after the evening meal. ELDERLY The elderly usually require lower dosage. CHILDREN There is no paediatric experience with glibenclamide, therefore its use cannot be recommended for children. DOSE OMISSION A physician should be consulted in the event that a dose has not been taken at the prescribed time, a meal has been skipped or an extra dose has been taken. It is very important not to skip meals after the tablets have been taken. SECONDARY DOSAGE ADJUSTMENT As an improvement in control of diabetes is, in itself, associated with higher insulin sensitivity, glibenclamide requirements may fall as treatme Leggi il documento completo